Treatment of Atopic Dermatitis Using a Full-Body Blue Light Device (AD-Blue): Protocol of a Randomized Controlled Trial

BACKGROUND: Irradiation with visible blue light (wavelength 400-495 nm) is a promising, effective, and safe new treatment option for chronic inflammatory skin diseases such as psoriasis and atopic dermatitis. OBJECTIVE: We will perform a multicenter, placebo-controlled, double-blinded, 3-armed, pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Kromer, Christian, Nühnen, Viktoria P, Pfützner, Wolfgang, Pfeiffer, Sebastian, Laubach, Hans-Joachim, Boehncke, Wolf-Henning, Liebmann, Joerg, Born, Matthias, Schön, Michael P, Buhl, Timo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329412/
https://www.ncbi.nlm.nih.gov/pubmed/30622089
http://dx.doi.org/10.2196/11911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329412/
https://www.ncbi.nlm.nih.gov/pubmed/30622089
http://dx.doi.org/10.2196/11911

Ejemplares similares